Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc., 8220 [2021-02315]
Download as PDF
<![CDATA[
8220
Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices
Authority: Section 2 of the Paperwork
Reduction Act of 1995, 44 U.S.C. 3507.
Colette Pollard,
Department Management Reports
Management Officer, Office of the Chief
Information Officer.
Controlled substance
Drug
code
Schedule
To submit
comments:
Send them to:
Remifentanil ......................
9739
II
By mail .........
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington,
D.C. 20044–7611.
The company plans to import the
above-controlled substance as the
Federal Drug Administration-approved
drug product in finished dosage form for
commercial distribution to its
customers. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2).
[FR Doc. 2021–02256 Filed 2–3–21; 8:45 am]
BILLING CODE 4210–67–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–773]
DEPARTMENT OF JUSTICE
During the public comment period,
the proposed consent decree may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
proposed consent decree upon written
request and payment of reproduction
costs. Please mail your request and
payment to: Consent Decree Library,
U.S. DOJ—ENRD, P.O. Box 7611,
Washington, DC 20044–7611.
Please enclose a check or money order
for $8.50 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act (‘‘CAA’’)
Jeffrey Sands,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
William T. McDermott,
Assistant Administrator.
Importer of Controlled Substances
Application: Mylan Pharmaceuticals
Inc.
[FR Doc. 2021–02315 Filed 2–3–21; 8:45 am]
BILLING CODE P
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Mylan Pharmaceuticals Inc.
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 8, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 8, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on December 18, 2020,
Mylan Pharmaceuticals Inc., 2898
Manufacturers Road, Greensboro, North
Carolina 27406–4600, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:13 Feb 03, 2021
Jkt 253001
On January 29, 2021, the Department
of Justice lodged a proposed consent
decree with the United States District
Court for the District of Utah in the
lawsuit entitled United States v.
Stericycle, Inc., Civil Action No. 1:21–
cv–00012–JNP.
The United States filed this lawsuit
under the Clean Air Act alleging
violations of NOx emission limits at
Stericycle, Inc.’s medical waste
incinerator in North Salt Lake, Utah (an
ozone nonattainment area) and other
related violations. The proposed
consent decree will require Stericycle to
pay a $600,000 civil penalty and
conduct a supplemental environmental
project to replace 15–20 pre-2006 diesel
school buses with low emitting models
at an estimated cost of $2,000,000.
The publication of this notice opens
a period for public comment on the
proposed consent decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States v. Stericycle, Inc.,
D.J. Ref. No. 90–5–2–1–12057. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
[FR Doc. 2021–02353 Filed 2–3–21; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Alternative
Method of Compliance for Certain
Simplified Employee Pensions
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this EBSAsponsored information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that agency receives
on or before March 8, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Comments are invited on: (1) Whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
SUMMARY:
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 86, Number 22 (Thursday, February 4, 2021)]
[Notices]
[Page 8220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02315]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-773]
Importer of Controlled Substances Application: Mylan
Pharmaceuticals Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Mylan Pharmaceuticals Inc. has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before March 8, 2021.
Such persons may also file a written request for a hearing on the
application on or before March 8, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on December 18, 2020, Mylan Pharmaceuticals Inc., 2898
Manufacturers Road, Greensboro, North Carolina 27406-4600, applied to
be registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Remifentanil........................... 9739 II
------------------------------------------------------------------------
The company plans to import the above-controlled substance as the
Federal Drug Administration-approved drug product in finished dosage
form for commercial distribution to its customers. Approval of permit
applications will occur only when the registrant's business activity is
consistent with what is authorized under 21 U.S.C. 952(a)(2).
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-02315 Filed 2-3-21; 8:45 am]
BILLING CODE P
